First Header Logo Second Header Logo

Connection

Roy Hantgan to Drug Design

Back to Details
This is a "connection" page, showing publications Roy Hantgan has written about Drug Design.
Roy Hantgan
Connection Strength
0.007
Drug Design
  1. Carr ME, Carr SL, Hantgan RR, Braaten J. Glycoprotein IIb/IIIa blockade inhibits platelet-mediated force development and reduces gel elastic modulus. Thromb Haemost. 1995 Mar; 73(3):499-505.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.